Healthtech Platform BeatO Raises Rs 42 Cr Pre-Series B Funding

BeatO, a healthtech platform offering a digital care ecosystem for chronic condition management, has raised Rs 42 crore in funding.

The funding round was led by US-based venture capital firm W Health Ventures and also saw participation from PharmEasy, Merisis VP, and existing investors Orios VP, Leo Capital, and others.

As per the startup, it will use the funding towards growing its subscriber base across multiple channels and geographies. BeatO will also use the raised amount for product enhancement to provide care for more cardiometabolic conditions.

Started by Yash Sehgal, Abhishek Kumar and Gautam Chopra, BeatO is a Delhi-NCR based healthtech startup offering a full-stack platform with products across categories for diabetics. The platform enables people to make smarter decisions by providing personalized insights on the app based on their health profile and blood glucose trends.

With this funding, online pharmacy startup Pharmeasy is also looking to partner with BeatO towards building technology and new products, improving the health outcomes of patients with chronic conditions across both platforms.

Speaking on the development, Gautam Chopra, Co-founder and CEO of BeatO, said,

“With our holistic tech-based solution that supports end to end management for these conditions, we have a proven product and technology with a highly engaged and rapidly growing member base. We welcome our new partners in our exciting journey as we continue to address this large problem and positively impact millions of lives.”

The startup claims that its revenues grew 600% last year and has 500,000 app installs with 300,000 paid members (adding 25,000 paid members every month).

Need legal assistance for your startup? Just contact us.

Follow us and connect with us on Instagram, Facebook, Twitter and LinkedIn.